Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann M Ranger

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Lupus Science & Medicine|June 27, 2015
BAFF (B cell activating factor) transcript level in peripheral blood of patients with SLE is associated with same-day disease activity as well as global activity over the next yearEric Zollars, Jadwiga Bienkowska, Julie Czerkowicz, et al.
The Journal of Biological Chemistry|May 16, 2002
Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptorAndrew P Gilmore, Anthony J Valentijn, Pengbo Wang, et al.
Annals of the Rheumatic Diseases|August 7, 2017
Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profilesChris Chamberlain, Peter J Colman, Ann M Ranger, et al.
Developmental Cell|November 15, 2002
Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosisSandeep Robert Datta, Ann M Ranger, Michael Z Lin, et al.
The Journal of Biological Chemistry|July 3, 2004
BAD is a pro-survival factor prior to activation of its pro-apoptotic functionSo Young Seo, Ying-Bei Chen, Iva Ivanovska, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2003
Bad-deficient mice develop diffuse large B cell lymphomaAnn M Ranger, Jiping Zha, Hisashi Harada, et al.
EMBO Molecular Medicine|March 13, 2015
Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanismsAlex Pellerin, Karel Otero, Julie M Czerkowicz, et al.
Nature|August 22, 2003
BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosisNika N Danial, Colette F Gramm, Luca Scorrano, et al.
Plos One|October 21, 2016
Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like FibrosisAgnes Gardet, Wei C Chou, Taylor L Reynolds, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Lupus Science & Medicine|June 27, 2015
BAFF (B cell activating factor) transcript level in peripheral blood of patients with SLE is associated with same-day disease activity as well as global activity over the next yearEric Zollars, Jadwiga Bienkowska, Julie Czerkowicz, et al.
The Journal of Biological Chemistry|May 16, 2002
Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptorAndrew P Gilmore, Anthony J Valentijn, Pengbo Wang, et al.
Annals of the Rheumatic Diseases|August 7, 2017
Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profilesChris Chamberlain, Peter J Colman, Ann M Ranger, et al.
Developmental Cell|November 15, 2002
Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosisSandeep Robert Datta, Ann M Ranger, Michael Z Lin, et al.
The Journal of Biological Chemistry|July 3, 2004
BAD is a pro-survival factor prior to activation of its pro-apoptotic functionSo Young Seo, Ying-Bei Chen, Iva Ivanovska, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2003
Bad-deficient mice develop diffuse large B cell lymphomaAnn M Ranger, Jiping Zha, Hisashi Harada, et al.
EMBO Molecular Medicine|March 13, 2015
Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanismsAlex Pellerin, Karel Otero, Julie M Czerkowicz, et al.
Nature|August 22, 2003
BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosisNika N Danial, Colette F Gramm, Luca Scorrano, et al.
Plos One|October 21, 2016
Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like FibrosisAgnes Gardet, Wei C Chou, Taylor L Reynolds, et al.
Pageof 1